Review article: Diagnosis, monitoring and treatment of distal colitis

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 17, Issue 2, 2003, Pages 2-6

  Vecchi, M ^a   Saibeni, S ^a   Devani, M ^a   Rondonotti, E ^a   De Franchis, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; CORTICOSTEROID; MESALAZINE; SALAZOSULFAPYRIDINE; STEROID;

ABDOMINAL PAIN; ACUTE DISEASE; ANAMNESIS; BLOOD ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; DIFFERENTIAL DISPLAY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ENDOSCOPY; ERYTHEMA; FECES CULTURE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAINTENANCE THERAPY; MICROBIOLOGICAL EXAMINATION; PARASITE CULTIVATION; PATIENT MONITORING; PRIORITY JOURNAL; RADIODIAGNOSIS; RECTUM HEMORRHAGE; REMISSION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; TREATMENT CONTRAINDICATION; ULCERATIVE COLITIS; WORKSHOP;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADMINISTRATION, RECTAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; COLITIS, ULCERATIVE; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL HEMORRHAGE; MEDICAL HISTORY TAKING; MESALAMINE; RECTAL DISEASES;

EID: 0038574376     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 255-81.
2. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 1997; 92: 204-11.
3. Ardizzone S, Bianchi Porro G. A practical guide to the management of distal ulcerative colitis. Drugs 1998; 55: 519-42.
4. Modigliani R. Endoscopic management of Inflammatory Bowel Disease. Am J Gastroenterol Supplement 1994; 8: 53-65.
5. Waye JD. Endoscopy in Inflammatory Bowel Disease. In: Inflammatory Bowel Disease. Kirsner JD, Shorter RG, ed. Philadelphia: Lea and Fabiger, 1988; 353-76.
6. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998; 115: 822-9.
7. Pera A, Bellando P, Caldera D, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987; 92: 181-5.
8. Surawicz CM. Differential diagnosis of colitis. In: Inflammatory Bowel Disease: from Bench to Bedside. Targan SR, Shanahan F, eds. Baltimore: Williams & Wilkins, 1994; 409-28.
9. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 2: 1041-5.
10. Rachmilewicz D. Coated mesalazine (5 aminosalicylic acid) versus sulfasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 1989; 298: 82-6.
11. Hanauer SB. Measurements of disease activity. In: Inflammatory Bowel Disease: from Bench to Beside. Targan SR, Shanahan F. eds. Baltimore: Williams & Wilkins. 1994; 424-44.
12. Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000; 95: 1263-76.
13. Gisbert JP, Gomollón F, Maté J, Pajares JM. Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory Bowel Disease. A systematic review. Dig Dis Sci 2002; 47: 471-88.
14. Campieri M, Lanfranchi GA, Bazzocchi G, et al. Treatment of ulcerative colitis with high dose 5 aminosalicylic acid enemas. Lancet 1981; ii: 270-1.
15. Campieri M, Gionchetti P, Belluzzi A, et al. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut 1991; 32: 929-31.
16. Campieri M, Corbelli C, Gionchetti P, et al. Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Dig Dis Sci 1992; 37: 1890-7.
17. Gionchetti P, Rizzello P, Venturi A, et al. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Dis Col Rectum 1998; 41: 93-7.
18. Safdi M, De Micco M, Sninsky C, et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol 1997; 92: 1867-7.
19. Vecchi M, Meucci G, Giochetti P, et al. Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, raandomized multicentre study. Aliment Pharmacol Ther 2001; 15: 251-6.
20. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997; 40: 775-81.
21. Mulder CJJ, Fockens P, Meijer JWR, van der Heide H, Wiltink EHH, Tytgat GNJ. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. Eur J Gastroent Hepatol 1996; 8: 549-53.
22. Goodman MW, Eberle DE, Kuchler LA, Fossum EA. Microscopic activity predicts relapse in patients with distal ulcerative colitis on 4-aminosalicylic acid enemas. Gastroenterology 1988; 96: A151. (Abstract)
23. Courtney MG, Nunes MB, Bergin CF, et al. Colonoscopic but no histological appearances determine likelihood of relapse of ulcerative colitis. Am J Gastroenterol 1991; 86: 243.
24. Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity in ulcerative colitis: what does it mean? Gut 1991; 32: 174-8.
25. Misiewicz JJ, Lennard-Jones JE, Connell AM, et al. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet 1965; 1: 185-8.
26. de Franchis R, Vecchi M, Carpinelli L, Meucci G, Torgano G. Comparison of the efficacy and safety of sulphasalazine and mesalazines in the maintenance treatment of ulcerative colitis: a meta-analysis. Eur J Gastroenterol Hepatol 1993; 5: 505-10.
27. Biddle W, Greenberger NJ, Swan JT, McPhee MS, Miner PB Jr. 5-aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988; 95: 1075-9.
28. Meucci G, Vecchi M, Astegiano M, et al. on behalf of the GSMII (Gruppo per le Malattie Infiammatorie Intestinali). The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol 1999; 95: 469-73.